Versant Ventures, Eli Lilly, and a handful of other investors will pour $100 million into a new startup devoted to solving a ...
Venture capitalist John Doerr on Tom Health, a new AI tool for primary care: "I think this is one of the best possible uses ...
The language around self-care for doctors puts the onus on them to fix themselves. But the system is to blame, writes Frances ...
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has ...
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become ...
The Trump administration proposed new regulations Monday that top officials say would “prevent fraud, remove bad actors, and ...
The acting director of NIAID, John Powers III, will become the permanent director, the agency announced Monday.
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious ...
Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data ...
It doesn’t have quite the same ring to it as “Medicare for All.” But House Dems have coalesced around a policy priority to ...
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results